•  
  •  
  •  
  •  

2026-07-23 05:30:46

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Tanla Platforms Reports Strong Q1 FY27 Results with Net Profit Rising 20.1% YoY to ₹142 Crore
  • United Spirits Limited Reports Q1 FY27 Results with Consolidated Net Profit Rising to ₹463 Crore
  • Mahindra Lifespaces and Sumitomo Corporation strengthen partnership to expand Origins by Mahindra in Chennai
  • Waaree Renewable Technologies Delivers Strong Q1 FY27 Performance with 53.23% Revenue Surge to ₹924.25 Crore
  • Signatureglobal Homes Ltd acquires saleable area of 0.38 mn sq.ft

Keywords Selected:  EIR

Stock Report

  • Vraj Iron and Steel Unveils ₹450 Crore Greenfield Integrated Plant in Chhattisgarh
  • Ajanta Pharma Ltd receives EIR from USFDA for Paithan facility
  • Lupin Receives EIR from U.S. FDA for its Somerset Facility with VAI Classification
  • CIL takes steps to offer more coal to NRS
  • Granules Pharmaceuticals, Inc. Receives USFDA EIR for Chantilly Facility
  • Lupin's Ankleshwar Facility Receives EIR from U.S. FDA
  • Supriya Lifescience Receives USFDA EIR with VAI Classification for Maharashtra API Facility
  • Zydus receives EIR for oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Vraj Iron and Steel Ltd granted exemption from payment of electricy duty
  • Vraj Iron and Steel Ltd commissions Induction Furnace Unit
  • Granules India's Packaging Facility in US gets FDA EIR with No Action Indicated Status
  • Godawari Power and Ispat Ltd receives approval to operate enhanced capacity of Sponge Iron Division
  • Lupin Receives EIR from US FDA for its Goa Facility
  • Biocon Ltd receives EIR from USFDA with VAI status for Cranbury facility
  • Vraj Iron and Steel Ltd commissions solar power plant
  • Lupin receives EIR from US FDA for its Nagpur Injectable Facility
  • Granules Life Sciences Pvt Ltd facility receives EIR from USFDA
  • Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga
  • Zydus receives EIR for the injectable facility located at Jarod
  • Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for facility at Panelav
  • Lloyds Metals and Energy Ltd commissions 360 KTPA Sponge Iron plant at Ghugus
  • SMS Pharmaceuticals Ltd receives EIR from USFDA for Central Laboratory Analytical Services

Latest Post

  • Tanla Platforms Reports Strong Q1 FY27 Results with Net Profit Rising 20.1% YoY to ₹142 Crore
  • United Spirits Limited Reports Q1 FY27 Results with Consolidated Net Profit Rising to ₹463 Crore
  • Mahindra Lifespaces and Sumitomo Corporation strengthen partnership to expand Origins by Mahindra in Chennai
  • Waaree Renewable Technologies Delivers Strong Q1 FY27 Performance with 53.23% Revenue Surge to ₹924.25 Crore
  • Signatureglobal Homes Ltd acquires saleable area of 0.38 mn sq.ft


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025